leuprorelin

Italy

Drugs containing this active substance

  • CAMCEVI

    This medicine is used for the treatment of adult men with hormone-sensitive metastatic prostate cancer or high-risk hormone-sensitive non-metastatic prostate cancer in association with radiotherapy.

    Form: suspension for injection, prolonged-release in pre-filled syringe

    Active substance Dosage
    leuprorelin -

    ATC: L02AE02

    Manufacturer: ACCORD HEALTHCARE, S.L.U.

  • The drug is used to treat prostate cancer in men; endometriosis, breast cancer in women nearing menopause, and uterine fibroids in women; and precocious puberty in children.

    Form: solution for injection

    Active substance Dosage
    leuprorelin -

    ATC: L02AE02

    Manufacturer: TAKEDA ITALIA S.P.A.